These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 22007676)
21. Lipopeptides containing 2-(palmitoylamino)-6,7-bis(palmitoyloxy) heptanoic acid: synthesis, stereospecific stimulation of B-lymphocytes and macrophages, and adjuvanticity in vivo and in vitro. Metzger J; Jung G; Bessler WG; Hoffmann P; Strecker M; Lieberknecht A; Schmidt U J Med Chem; 1991 Jul; 34(7):1969-74. PubMed ID: 2066969 [TBL] [Abstract][Full Text] [Related]
22. Development of Zhou Y; Banday AH; Hruby VJ; Cai M Molecules; 2019 Sep; 24(19):. PubMed ID: 31569697 [TBL] [Abstract][Full Text] [Related]
23. Site-specific effect of polar functional group-modification in lipids of TLR2 ligands for modulating the ligand immunostimulatory activity. Arai Y; Inuki S; Fujimoto Y Bioorg Med Chem Lett; 2018 May; 28(9):1638-1641. PubMed ID: 29598910 [TBL] [Abstract][Full Text] [Related]
24. Development of a vaccine based on bacteria-mimicking tumor cells coated with novel engineered toll-like receptor 2 ligands. Akazawa T; Ohashi T; Wijewardana V; Sugiura K; Inoue N Cancer Sci; 2018 May; 109(5):1319-1329. PubMed ID: 29575556 [TBL] [Abstract][Full Text] [Related]
26. PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8 Sekiya T; Yamagishi J; Gray JHV; Whitney PG; Martinelli A; Zeng W; Wong CY; Sugimoto C; Jackson DC; Chua BY Biomaterials; 2017 Aug; 137():61-72. PubMed ID: 28544973 [TBL] [Abstract][Full Text] [Related]
30. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Kang JY; Nan X; Jin MS; Youn SJ; Ryu YH; Mah S; Han SH; Lee H; Paik SG; Lee JO Immunity; 2009 Dec; 31(6):873-84. PubMed ID: 19931471 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel immunologically active tripalmitoyl-S-glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations. Metzger J; Wiesmüller KH; Schaude R; Bessler WG; Jung G Int J Pept Protein Res; 1991 Jan; 37(1):46-57. PubMed ID: 2045219 [TBL] [Abstract][Full Text] [Related]
35. Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. Omueti KO; Beyer JM; Johnson CM; Lyle EA; Tapping RI J Biol Chem; 2005 Nov; 280(44):36616-25. PubMed ID: 16129684 [TBL] [Abstract][Full Text] [Related]
36. TLR2 Agonistic Small Molecules: Detailed Structure-Activity Relationship, Applications, and Future Prospects. Kaur A; Kaushik D; Piplani S; Mehta SK; Petrovsky N; Salunke DB J Med Chem; 2021 Jan; 64(1):233-278. PubMed ID: 33346636 [TBL] [Abstract][Full Text] [Related]
37. Soluble proteins induce strong CD8+ T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2. Chua BY; Pejoski D; Turner SJ; Zeng W; Jackson DC J Immunol; 2011 Aug; 187(4):1692-701. PubMed ID: 21742967 [TBL] [Abstract][Full Text] [Related]
38. A modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope building. Zeng W; Horrocks KJ; Robevska G; Wong CY; Azzopardi K; Tauschek M; Robins-Browne RM; Jackson DC J Biol Chem; 2011 Apr; 286(15):12944-51. PubMed ID: 21321114 [TBL] [Abstract][Full Text] [Related]
39. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Jin MS; Kim SE; Heo JY; Lee ME; Kim HM; Paik SG; Lee H; Lee JO Cell; 2007 Sep; 130(6):1071-82. PubMed ID: 17889651 [TBL] [Abstract][Full Text] [Related]
40. The second and third amino acids of Pam2 lipopeptides are key for the proliferation of cytotoxic T cells. Takeda Y; Azuma M; Hatsugai R; Fujimoto Y; Hashimoto M; Fukase K; Matsumoto M; Seya T Innate Immun; 2018 Jul; 24(5):323-331. PubMed ID: 29848176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]